Key result
Epicardial patches reduce scarring and improve function but overcoming the thick epicardial barrier remains challenging.
Why the study?
Epicardial patches are promising for myocardial repair in ischemic heart disease, but the thick epicardial barrier limits efficacy.
Epicardial patches represent a promising adjunctive strategy for myocardial repair, though overcoming the epicardial adipose tissue barrier remains a critical challenge for clinical translation.
Should not yet change practice after MI; extends patch evidence but leaves open epicardial adipose barrier penetration for translation.
Ischemic heart disease, which leads to the loss of functional myocardium, remains the leading cause of death in late adulthood. Epicardial patches have emerged as a promising adjunctive strategy for myocardial repair. However, owing to the thick epicardial barrier (epicardial adipose tissue), only a select few approaches have demonstrated reduced scarring and improved heart function in large animal models and early-stage human trials. In this opinion article, we examine the different mechanisms and approaches to overcome the epicardial barrier. We further discuss key design and material considerations to improve safety and efficacy in clinical applications. Finally, we provide a summary of current regulatory and clinical challenges, together with proposed future research directions and foci in the translation of epicardial patches.
No takes yet. Share an insight, caveat, or question.
Winkelbauer et al. (2026) studied this question. Epicardial patches can improve myocardial repair by reducing scarring and improving heart function, but overcoming the thick epicardial barrier remains a challenge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: